U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LITIFILIMAB
INN  
Official Name English
24F4A
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN BLOOD DENDRITIC CELL ANTIGEN 2) (HUMAN-MUS MUSCULUS MONOCLONAL BIIB059 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BIIB059 .KAPPA.-CHAIN, DIMER
Common Name English
BIIB059
Code English
LITIFILIMAB [USAN]
Common Name English
Litifilimab [WHO-DD]
Common Name English
BIIB-059
Code English
litifilimab [INN]
Common Name English
Code System Code Type Description
CAS
2407378-48-5
Created by admin on Mon Mar 31 22:38:44 GMT 2025 , Edited by admin on Mon Mar 31 22:38:44 GMT 2025
PRIMARY
USAN
HI-165
Created by admin on Mon Mar 31 22:38:44 GMT 2025 , Edited by admin on Mon Mar 31 22:38:44 GMT 2025
PRIMARY
SMS_ID
300000018722
Created by admin on Mon Mar 31 22:38:44 GMT 2025 , Edited by admin on Mon Mar 31 22:38:44 GMT 2025
PRIMARY
NCI_THESAURUS
C186413
Created by admin on Mon Mar 31 22:38:44 GMT 2025 , Edited by admin on Mon Mar 31 22:38:44 GMT 2025
PRIMARY
INN
11943
Created by admin on Mon Mar 31 22:38:44 GMT 2025 , Edited by admin on Mon Mar 31 22:38:44 GMT 2025
PRIMARY
FDA UNII
V27E9V3K7G
Created by admin on Mon Mar 31 22:38:44 GMT 2025 , Edited by admin on Mon Mar 31 22:38:44 GMT 2025
PRIMARY
ACTIVE MOIETY
LITIFILIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966